Director Amy E. Alving filed a Form 4 with the SEC on September 22, 2026, disclosing the acquisition of dividend equivalent rights tied to restricted stock units in Versigent PLC (NYSE:VGNT), with the transaction dated September 18, 2026.

Key Highlights

  • Reporting person: Amy E. Alving, listed as a Director of Versigent PLC.
  • Transaction type: Acquisition (Code A) of 14.65 dividend equivalent rights on September 18, 2026.
  • Price: The dividend equivalent rights were acquired at $0.00 per right, according to the filing.
  • Post-transaction holdings: Alving beneficially owns 14.65 dividend equivalent rights directly following the reported transaction.
  • Nature of rights: The filing states these rights accrued on restricted stock unit grants as a result of a dividend declared and paid by the issuer, vesting on the same schedule as the underlying restricted stock units.
  • Economic equivalence: According to the filing, each dividend equivalent right is the economic equivalent of one ordinary share of the issuer.

Versigent PLC Director Discloses Dividend Equivalent Rights Tied to RSU Grants

According to the Form 4 filed on September 22, 2026, Amy E. Alving, a director of Versigent PLC (NYSE:VGNT), reported the acquisition of 14.65 dividend equivalent rights. The transaction date is listed as September 18, 2026, and the filing was signed by Janis N. Acosta as attorney-in-fact for Alving. The form was filed as an individual, single-person filing.

The filing's explanation of responses states that "the dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer." The rights are reported as direct ownership and carry a transaction price of $0.00. Following the reported transaction, Alving's total beneficially owned position in these derivative securities stands at 14.65 rights.

The filing further discloses that these rights "vest on the same schedule as the restricted stock units to which they relate" and that "each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares." The underlying security identified in Table II is listed as ordinary shares of Versigent PLC. No non-derivative securities transactions were reported in Table I of this filing.

What Was Disclosed

Director Amy E. Alving disclosed the acquisition of 14.65 dividend equivalent rights in Versigent PLC at $0.00, accrued from RSU grants following a company dividend. The rights vest on the same schedule as the related restricted stock units.